Cargando…
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside
Mucositis is one of the most common debilitating side effects related to chemotherapy (CT), radiation therapy (RT), targeted agents and immunotherapy. It is a complex process potentially involving any portion of the gastrointestinal tract and injuring the mucosa, leading to inflammatory or ulcerativ...
Autores principales: | Basile, Debora, Di Nardo, Paola, Corvaja, Carla, Garattini, Silvio Ken, Pelizzari, Giacomo, Lisanti, Camilla, Bortot, Lucia, Da Ros, Lucia, Bartoletti, Michele, Borghi, Matteo, Gerratana, Lorenzo, Lombardi, Davide, Puglisi, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627284/ https://www.ncbi.nlm.nih.gov/pubmed/31226812 http://dx.doi.org/10.3390/cancers11060857 |
Ejemplares similares
-
Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
por: Bartoletti, Michele, et al.
Publicado: (2020) -
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker
por: Pelizzari, Giacomo, et al.
Publicado: (2019) -
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2020) -
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Garattini, Silvio Ken, et al.
Publicado: (2021) -
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
por: Basile, Debora, et al.
Publicado: (2019)